Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase IV Pharmacovigilance, Post-Authorization Clinical Trial To Evaluate And Assess The Safety Of Tigecycline In The Approved Indications In The Usual Health Care Setting

NCT00827541 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.

NCT NCT00827541
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00827541 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase IV Pharmacovigilance, Post-Authorization Clinical Trial To Evaluate And Assess The Safety Of Tigecycline In The Approved Indications In The Usual Health Care Setting
Lead sponsor
Pfizer
Phase
Observational
Overall status
Completed
Start date
August 31, 2008
Completion date
December 31, 2010
Enrollment
115 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

intra-abdominal infections, skin disease, infectious, soft tissues infections